Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging

Zhen Luo, Kiana Michelle Samadzadeh, Nitin Nitin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The overall goal of this study was to evaluate optical molecular imaging approaches to determine the drug response of chemotherapy and molecular targeted agents in drug sensitive and drug resistant cell lines. The optical molecular imaging approaches selected in this study were based on changes in intracellular uptake and retention of choline and glucose molecules. The breast cancer cell lines were treated with a molecular targeted anti-EGFR therapy. The bladder cancer cell lines were treated with a conventional chemotherapy approach. Sensitivity of optical molecular imaging approach was also compared with conventional cell viability and cell growth inhibition assays. Results demonstrate that optical molecular imaging of changes in intracellular uptake of metabolites was effective in detecting drug susceptibility for both molecular targeted therapy in breast cancer cells and chemotherapy in bladder cancer cells. Between the selected metabolites for optical molecular imaging, changes in glucose metabolic activity showed higher sensitivity in discrimination between the drug sensitive and drug resistant cell lines. The results demonstrated that optical molecular imaging approaches more significantly sensitive as compared to the conventional cell viability and growth assays. Overall, the results demonstrate potential of optical molecular imaging of metabolic activity to improve sensitivity of in-vitro drug response assays.

Original languageEnglish (US)
Pages (from-to)50-58
Number of pages9
JournalAnalytical Biochemistry
Volume504
DOIs
StatePublished - Jul 1 2016

Fingerprint

Molecular Imaging
Molecular imaging
Optical Imaging
Carboplatin
Drug Resistance
Cells
Imaging techniques
Pharmaceutical Preparations
Chemotherapy
Neoplasms
Cell Line
Assays
Urinary Bladder Neoplasms
Drug Therapy
Metabolites
Cell Survival
Molecular Targeted Therapy
Breast Neoplasms
Glucose
Growth

Keywords

  • Chemotherapy
  • Drug response
  • Metabolic activity
  • Molecular imaging
  • Molecular targeted therapy

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology
  • Cell Biology

Cite this

Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging. / Luo, Zhen; Samadzadeh, Kiana Michelle; Nitin, Nitin.

In: Analytical Biochemistry, Vol. 504, 01.07.2016, p. 50-58.

Research output: Contribution to journalArticle

Luo, Zhen ; Samadzadeh, Kiana Michelle ; Nitin, Nitin. / Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging. In: Analytical Biochemistry. 2016 ; Vol. 504. pp. 50-58.
@article{c2b4fbba542e4dcd944b20e20f9f0b79,
title = "Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging",
abstract = "The overall goal of this study was to evaluate optical molecular imaging approaches to determine the drug response of chemotherapy and molecular targeted agents in drug sensitive and drug resistant cell lines. The optical molecular imaging approaches selected in this study were based on changes in intracellular uptake and retention of choline and glucose molecules. The breast cancer cell lines were treated with a molecular targeted anti-EGFR therapy. The bladder cancer cell lines were treated with a conventional chemotherapy approach. Sensitivity of optical molecular imaging approach was also compared with conventional cell viability and cell growth inhibition assays. Results demonstrate that optical molecular imaging of changes in intracellular uptake of metabolites was effective in detecting drug susceptibility for both molecular targeted therapy in breast cancer cells and chemotherapy in bladder cancer cells. Between the selected metabolites for optical molecular imaging, changes in glucose metabolic activity showed higher sensitivity in discrimination between the drug sensitive and drug resistant cell lines. The results demonstrated that optical molecular imaging approaches more significantly sensitive as compared to the conventional cell viability and growth assays. Overall, the results demonstrate potential of optical molecular imaging of metabolic activity to improve sensitivity of in-vitro drug response assays.",
keywords = "Chemotherapy, Drug response, Metabolic activity, Molecular imaging, Molecular targeted therapy",
author = "Zhen Luo and Samadzadeh, {Kiana Michelle} and Nitin Nitin",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.ab.2016.03.021",
language = "English (US)",
volume = "504",
pages = "50--58",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging

AU - Luo, Zhen

AU - Samadzadeh, Kiana Michelle

AU - Nitin, Nitin

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The overall goal of this study was to evaluate optical molecular imaging approaches to determine the drug response of chemotherapy and molecular targeted agents in drug sensitive and drug resistant cell lines. The optical molecular imaging approaches selected in this study were based on changes in intracellular uptake and retention of choline and glucose molecules. The breast cancer cell lines were treated with a molecular targeted anti-EGFR therapy. The bladder cancer cell lines were treated with a conventional chemotherapy approach. Sensitivity of optical molecular imaging approach was also compared with conventional cell viability and cell growth inhibition assays. Results demonstrate that optical molecular imaging of changes in intracellular uptake of metabolites was effective in detecting drug susceptibility for both molecular targeted therapy in breast cancer cells and chemotherapy in bladder cancer cells. Between the selected metabolites for optical molecular imaging, changes in glucose metabolic activity showed higher sensitivity in discrimination between the drug sensitive and drug resistant cell lines. The results demonstrated that optical molecular imaging approaches more significantly sensitive as compared to the conventional cell viability and growth assays. Overall, the results demonstrate potential of optical molecular imaging of metabolic activity to improve sensitivity of in-vitro drug response assays.

AB - The overall goal of this study was to evaluate optical molecular imaging approaches to determine the drug response of chemotherapy and molecular targeted agents in drug sensitive and drug resistant cell lines. The optical molecular imaging approaches selected in this study were based on changes in intracellular uptake and retention of choline and glucose molecules. The breast cancer cell lines were treated with a molecular targeted anti-EGFR therapy. The bladder cancer cell lines were treated with a conventional chemotherapy approach. Sensitivity of optical molecular imaging approach was also compared with conventional cell viability and cell growth inhibition assays. Results demonstrate that optical molecular imaging of changes in intracellular uptake of metabolites was effective in detecting drug susceptibility for both molecular targeted therapy in breast cancer cells and chemotherapy in bladder cancer cells. Between the selected metabolites for optical molecular imaging, changes in glucose metabolic activity showed higher sensitivity in discrimination between the drug sensitive and drug resistant cell lines. The results demonstrated that optical molecular imaging approaches more significantly sensitive as compared to the conventional cell viability and growth assays. Overall, the results demonstrate potential of optical molecular imaging of metabolic activity to improve sensitivity of in-vitro drug response assays.

KW - Chemotherapy

KW - Drug response

KW - Metabolic activity

KW - Molecular imaging

KW - Molecular targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84967317259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967317259&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2016.03.021

DO - 10.1016/j.ab.2016.03.021

M3 - Article

C2 - 27059751

AN - SCOPUS:84967317259

VL - 504

SP - 50

EP - 58

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

ER -